Ben Burnett
Stock Analyst at Stifel
(n/a)
# 4,632
Out of 4,789 analysts
5
Total ratings
n/a
Success rate
-79.43%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Ben Burnett
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| JSPR Jasper Therapeutics | Initiates: Buy | $86 | $4.14 | +1,977.29% | 1 | Jun 27, 2024 | |
| CABA Cabaletta Bio | Maintains: Buy | $32 | $1.17 | +2,635.04% | 3 | Jun 17, 2024 | |
| CRSP CRISPR Therapeutics AG | Initiates: Hold | $52 | $33.14 | +56.91% | 1 | Mar 5, 2020 |
Jasper Therapeutics
Jun 27, 2024
Initiates: Buy
Price Target: $86
Current: $4.14
Upside: +1,977.29%
Cabaletta Bio
Jun 17, 2024
Maintains: Buy
Price Target: $32
Current: $1.17
Upside: +2,635.04%
CRISPR Therapeutics AG
Mar 5, 2020
Initiates: Hold
Price Target: $52
Current: $33.14
Upside: +56.91%